8th Symposium 2022

The 8^th Symposium “Advances in Cancer Immunology & Immunotherapy” is an intensive, three days interactive meeting during which invited speakers will address the current and accumulated knowledge of basic immuno-biology and translational cancer research, as well as therapeutic developments in the field of cancer immunotherapy according to the newest clinical trials.

The scientific objectives of the 8^th Symposium “Advances in Cancer Immunology and Immunotherapy” are focused on the: (a) predictive and prognostic biomarkers for immunotherapy (b) mechanisms of action of different immunotherapeutic treatments (c) the efficacy and safety data of cancer immunotherapy regimens; and (d) strategies for immunomodulation, counteracting resistance and mitigating adverse events.

This year’s Symposium will feature world-renowned oncologists and researchers who will provide their insights on the above mentioned  topics in an effort to better understand tumor evolution and designing improved treatment strategies.

The 8^th Symposium “Advances in Cancer Immunology and Immunotherapy” welcome the participation of scientists, clinicians, students and health care professionals interested in the field of Cancer Immunology and Immunotherapy.

The Organizing Committee

Athanasios Kotsakis
MD, PhD, Professor of Medical Oncology, School of Medicine, University of Thessaly, Larissa , Greece

Ourania Tsitsilonis
MD, PhD, Professor of Immunology, Department of Biology, National and Kapodistrian University of Athens, Greece

Constantin N. Baxevanis
Scientific Director, Cancer Immunology and Immunotherapy Center “St.Savvas” Cancer Hospital, Athens, Greece

Graham Pawelec
Professor of Experimental Immunology, Center of Medical Research, Department of Immunology, University of Tuebingen, Germany

Monica Neagu
Head of Immunology Department, “Victor Babes” National Institute of Pathology, Bucharest, Romania President of the Romanian Immunology Society, Romania

Suzanne Ostrand-Rosenberg
Adjunct Professor of Pathology Huntsman Cancer Institute (HCL),
University of Utah, USA

Jörg Wischhusen 
Professor of Experimental Tumor Immunology University of Würzburg School of Medicine Department of Gynecology and Obstetrics, Germany